Upregulation of phosphodiesterase-4 in the lung of allergic rats

American Journal of Respiratory and Critical Care Medicine

Volumn 171, Issue 8, 2005, Pages 823-828

  Tang, Hui Fang ^b   Song, Yan Hua ^b   Chen, Jun Chun ^b   Chen, Ji Qiang ^b   Wang, Peng ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NONE

Author keywords

Asthma; cAMP; PDE4; Phosphodiesterase 4; Rat

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; DEXAMETHASONE; INTERLEUKIN 4; MESSENGER RNA; OVALBUMIN; PHOSPHODIESTERASE IV; ROLIPRAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EXPERIMENTAL MODEL; GENE EXPRESSION; LUNG RESISTANCE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROVOCATION; RAT; SENSITIZATION; STATISTICAL SIGNIFICANCE; UPREGULATION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; AIRWAY RESISTANCE; ANIMALS; ASTHMA; DEXAMETHASONE; INTERLEUKIN-4; LUNG; MALE; OVALBUMIN; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY HYPERSENSITIVITY; RNA, MESSENGER; ROLIPRAM; TRACHEA; UP-REGULATION;

EID: 17644382915     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200406-771OC     Document Type: Article

References (41)

1. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995;75:725-748.
2. Conti M, Jin SLC. The molecular biology of cyclic nucleotide phosphodiesterases. Prog Nucleic Acid Res Mol Biol 2000;63:1-38.
3. Conti M, Richter W, Mehats C, Livera G, Park JY, Jin C. Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem 2003;278:5493-5496.
4. Francis SH, Turko IV, Corbin JD. Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucleic Acid Res Mol Biol 2001;65:1-52.
5. Houslay MD. PDE4 cAMP-specific phosphodiesterases. Prog Nucleic Acid Res Mol Biol 2001;69:249-315.
6. Manganiello VC, Murata T, Taira M, Belfrage P, Degerman E. Diversity in cyclic nucleotide phosphodiesterase isozyme families. Arch Biochem Biophys 1995;322:1-13.
7. Giembycz MA. Development status of second generation PDE4 inhibitors for asthma and COPD: the story so far. Monaldi Arch Chest Dis 2002;57:48-64.
8. Norman P. PDE4 inhibitors 2001: Patent and literature activity 2002-September 2001. Expert Opin Ther Patents 2002;12:93-111.
9. Renz H. Soluble interleukin-4 receptor (sIL-4R) in allergic diseases. Inflamm Res 1999;48:425-431.
10. Ryan JJ. Interleukin-4 and its receptor: essential mediators of the allergic response. J Allergy Clin Immunol 1997;99:1-5.
11. Wills-Karp M, Gavett SH, Schofield B, Finkelman F. Role of interleukin-4 in the development of allergic airway inflammation and airway hyperresponsiveness. Adv Exp Med Biol 1996;409:343-347.
12. Li SH, Chan SC, Toshitani A, Leung DYM, Hanifin JM. Synergistic effects of interleukin 4 and interferon-gamma on monocyte phosphodiesterase activity. J Invest Dermatol 1992;99:65-70.
13. Castillo JG, Gamboa PM, Garcia BE, Oehling A. Effect of ketotifen on phosphodiesterase activity from asthmatic individuals. Allergol Immunopathol (Madr) 1990;18:197-201.
14. Crocker C, Church MK, Ohia SE, Townley RG. Beclomethasone decreases elevations in phosphodiesterase activity in human T lymphocytes. Int Arch Allergy Immunol 2000;121:151-160.
15. Hanifin JM, Chan SC. Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis. J Invest Dermatol 1995;105:84S-88S.
16. Mue S, Ise T, Shibahara S, Takahashi M, Ono Y. Leukocyte cyclic-3′, 5′-nucleotide phosphodiesterase activity in human bronchial asthma. Ann Allergy 1976;37:201-207.
17. Sawai T, Ikai K, Uehara M. Cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from patients with atopic dermatitis: correlation with respiratory atopy. Br J Dermatol 1998;138:846-848.
18. Chan SC, Li SH, Hanifin JM. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. J Invest Dermatol 1993;100:681-684.
19. Coulson IH, Duncan SN, Holden CA. Peripheral blood mononuclear leukocyte cyclic adenosine monophosphate specific phosphodiesterase activity in childhood atopic dermatitis. Br J Dermatol 1989;120:607-612.
20. Gantner F, Tenor H, Gekeler V, Schudt C, Wendel A, Hatzelmann A. Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study. J Allergy Clin Immunol 1997;100:527-535.
21. Landells LJ, Spina D, Souness JE, O'Connor BJ, Page CP. A biochemical and functional assessment of monocyte phosphodiesterase activity in healthy and asthmatic subjects. Pulm Pharmacol Ther 2000;13:231-239.
22. Landells LJ, Szilagy CM, Jones NA, Banner KH, Allen JM, Doherty A, O'Connor BJ, Spina D, Page CP. Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects. Br J Pharmacol 2001;133:722-729.
23. Xie QM, Zeng LH, Zheng YX, Lu YB, Yang QH. Bronchodilating effects of bambuterol on bronchoconstriction in guinea pigs. Acta Pharmacol Sin 1999;20:651-654.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
25. Naro F, Sette C, Vicini E, De Arcangelis V, Grange M, Conti M, Lagarde M, Molinaro M, Adamo S, Nemoz G. Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells. Mol Biol Cell 1999;10:4355-4367.
26. Kostic MM, Erdogan S, Rena G, Borchert G, Hoch B, Bartel S, Scotland G, Huston E, Houslay MD, Krause EG. Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart. J Mol Cell Cardiol 1997;29:3135-3146.
27. Torphy TJ. Phosphodiesterase isozymes, molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 1998;157:351-370.
28. Ma D, Wu P, Egan RW, Billah MM, Wang P. Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes. Mol Pharmacol 1999;55:50-57.
29. Wang P, Wu P, Ohleth KM, Egan RW, Billah MM. Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils. Mol Pharmacol 1999;56:170-174.
30. 2-adrenoceptor desensitization in vivo. J Clin Invest 2000;106:125-135.
31. Singh SP, Barrett EG, Kalra R, Razani-Boroujerdi S, Langley RJ, Kurup V, Tesfaigzi Y, Sopori ML. Prenatal cigarette smoke decreases lung cAMP and increases airway hyperresponsiveness. Am J Respir Crit Care Med 2003;168:342-347.
32. Ahmad F, Gao G, Wang LM, Landstrom TR, Degerman JHP, Manganiello VC. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterase 3 and 4 by different mechanisms in FDCP2 myeloid cells. J Immunol 1999;162:4864-4875.
33. Huang TJ, Adcock IM, Chung KF. A novel transcription factor inhibitor, SP100030, inhibits cytokine gene expression, but not airway eosinophilia or hyperresponsiveness in sensitized and allergen-exposed rat. Br J Pharmacol 2001;134:1029-1036.
34. Lloyd CM, Gonzalo JA, Nguyen T, Delaney T, Tian J, Oettgen H, Coyle AJ, Gutierrez-Ramos JC. Resolution of bronchial hyperresponsiveness and pulmonary inflammation is associated with IL-3 and tissue leukocyte apoptosis. J Immunol 2001;166:2033-2040.
35. Almawi WY, Beyhum HN, Bahme AA, Rieder MJ. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol 1996;60:563-572.
36. Ahlstrom M, Pekkinen M, Huttunen M, Lamberg-Allardt C. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells. Biochem Pharmacol 2005;69:267-275.
37. 2- adrenoceptor agonists in asthma. Trends Pharmacol Sci 1996;17:331-336.
38. Kumar RK, Herbert C, Thomas PS, Wollin L, Beume R, Yang M, Webb D, Foster PS. Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. J Pharmacol Exp Ther 2003;307:349-355.
39. Toward TJ, Broadley KJ. Goblet cell hyperplasia, airway function, and leukocyte infiltration after chronic lipopolysaccharide exposure in conscious guinea pigs: effects of rolipram and dexamethasone. J Pharmacol Exp Ther 2002;302:814-821.
40. Jin SL, Conti M. Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses. Proc Natl Acad Sci USA 2002;99:7628-7633.
41. Mehats C, Jin SLC, Wahlstrom J, Law E, Umetsu DT, Conti M. PDE4D plays a critical role in the control of airway smooth muscle contraction. FASEB J 2003;17:1831-1841.